IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

BIT:IVG • NL0015000LU4

18.91 EUR
+0.07 (+0.37%)
Last: Feb 17, 2026, 09:54 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall IVG gets a fundamental rating of 4 out of 10. We evaluated IVG against 112 industry peers in the Machinery industry. While IVG is still in line with the averages on profitability rating, there are concerns on its financial health. IVG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • IVG had positive earnings in the past year.
  • IVG had a positive operating cash flow in the past year.
  • Of the past 5 years IVG 4 years were profitable.
  • In the past 5 years IVG always reported a positive cash flow from operatings.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

  • The Return On Assets of IVG (1.48%) is worse than 62.50% of its industry peers.
  • IVG has a Return On Equity of 10.01%. This is in the better half of the industry: IVG outperforms 66.96% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.89%, IVG is doing worse than 61.61% of the companies in the same industry.
  • IVG had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.74%.
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROIC 3.89%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • IVG has a worse Profit Margin (1.82%) than 62.50% of its industry peers.
  • In the last couple of years the Profit Margin of IVG has grown nicely.
  • IVG has a Operating Margin of 4.33%. This is in the lower half of the industry: IVG underperforms 60.71% of its industry peers.
  • IVG's Operating Margin has improved in the last couple of years.
  • IVG's Gross Margin of 16.00% is on the low side compared to the rest of the industry. IVG is outperformed by 90.18% of its industry peers.
  • IVG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.33%
PM (TTM) 1.82%
GM 16%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
  • IVG has less shares outstanding than it did 1 year ago.
  • IVG has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IVG has an improved debt to assets ratio.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • IVG has an Altman-Z score of 1.74. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
  • IVG's Altman-Z score of 1.74 is in line compared to the rest of the industry. IVG outperforms 41.96% of its industry peers.
  • IVG has a debt to FCF ratio of 9.94. This is a negative value and a sign of low solvency as IVG would need 9.94 years to pay back of all of its debts.
  • IVG has a worse Debt to FCF ratio (9.94) than 61.61% of its industry peers.
  • IVG has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.29, IVG is not doing good in the industry: 83.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Altman-Z 1.74
ROIC/WACC0.52
WACC7.42%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.91 indicates that IVG should not have too much problems paying its short term obligations.
  • IVG has a better Current ratio (1.91) than 66.07% of its industry peers.
  • A Quick Ratio of 1.38 indicates that IVG should not have too much problems paying its short term obligations.
  • IVG has a better Quick ratio (1.38) than 75.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.38
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.43%.
  • The Earnings Per Share has been growing by 32.82% on average over the past years. This is a very strong growth
  • IVG shows a decrease in Revenue. In the last year, the revenue decreased by -7.24%.
  • The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%

3.2 Future

  • IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
  • Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-25.28%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.11, the valuation of IVG can be described as correct.
  • Based on the Price/Earnings ratio, IVG is valued cheaper than 85.71% of the companies in the same industry.
  • IVG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 8.89, the valuation of IVG can be described as reasonable.
  • 91.07% of the companies in the same industry are more expensive than IVG, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, IVG is valued rather cheaply.
Industry RankSector Rank
PE 14.11
Fwd PE 8.89
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 73.21% of the companies in the same industry are more expensive than IVG, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, IVG is valued cheaply inside the industry as 80.36% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.72
EV/EBITDA 6.37
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.11%
EPS Next 3Y8.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.75%, IVG has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.48, IVG pays a bit more dividend than its industry peers.
  • IVG's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • IVG pays out 33.46% of its income as dividend. This is a sustainable payout ratio.
DP33.46%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IVECO GROUP NV

BIT:IVG (2/17/2026, 9:54:46 AM)

18.91

+0.07 (+0.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.13B
Revenue(TTM)14.48B
Net Income(TTM)263.00M
Analysts70.77
Price Target20.11 (6.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP33.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.41%
Min EPS beat(2)-69.38%
Max EPS beat(2)-15.44%
EPS beat(4)2
Avg EPS beat(4)-3.86%
Min EPS beat(4)-69.38%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)11.85%
EPS beat(12)7
Avg EPS beat(12)5.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-10.33%
Max Revenue beat(2)8.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-10.33%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.3%
Revenue beat(12)6
Avg Revenue beat(12)0.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.08%
EPS NY rev (1m)-3.77%
EPS NY rev (3m)-14.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.12%
Valuation
Industry RankSector Rank
PE 14.11
Fwd PE 8.89
P/S 0.35
P/FCF 8.72
P/OCF 3.61
P/B 1.95
P/tB 7.88
EV/EBITDA 6.37
EPS(TTM)1.34
EY7.09%
EPS(NY)2.13
Fwd EY11.25%
FCF(TTM)2.17
FCFY11.46%
OCF(TTM)5.23
OCFY27.67%
SpS53.38
BVpS9.69
TBVpS2.4
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17.09
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROCE 5.15%
ROIC 3.89%
ROICexc 4.75%
ROICexgc 5.91%
OM 4.33%
PM (TTM) 1.82%
GM 16%
FCFM 4.06%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Debt/EBITDA 2.49
Cap/Depr 112.3%
Cap/Sales 5.74%
Interest Coverage 250
Cash Conversion 103.8%
Profit Quality 223.57%
Current Ratio 1.91
Quick Ratio 1.38
Altman-Z 1.74
F-Score5
WACC7.42%
ROIC/WACC0.52
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-25.28%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-33.08%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y143.98%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y26.36%
OCF growth 3Y26.42%
OCF growth 5Y8.96%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for IVECO GROUP NV?

IVECO GROUP NV (IVG.MI) has a profitability rating of 4 / 10.


How financially healthy is IVECO GROUP NV?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


Can you provide the expected EPS growth for IVG stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -25.28% in the next year.